ArticleSurgery2014

Oncolytic immunotherapy using recombinant vaccinia virus GLV-1h68 kills sorafenib-resistant hepatocellular carcinoma efficiently.

Justin W Ady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.